61The dispute between the parties regarding the definition of the relevant product market centres on the competitive interaction between two pharmaceutical products, PPIs and H2 blockers. It is appropriate first of all to present those products succinctly.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.